About Multiply Labs
Multiply Labs is a company based in San Francisco (United States) founded in 2016 by Fred Parietti and Alice Melocchi. Multiply Labs has raised $41.32 million across 7 funding rounds from investors including Graph Ventures, Fenox Venture Capital and P101. The company has 34 employees as of December 31, 2024. Multiply Labs offers products and services including Robotic Systems for Cell Therapy and Digital QC. Multiply Labs operates in a competitive market with competitors including Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins, Cytera and Guangdong Bogong Medical Technology, among others.
- Headquarter San Francisco, United States
- Employees 34 as on 31 Dec, 2024
- Founders Fred Parietti, Alice Melocchi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Multiply Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.32 M (USD)
in 7 rounds
-
Latest Funding Round
$11.1 M (USD), Series A
Apr 21, 2023
-
Investors
Graph Ventures
& 12 more
-
Employee Count
34
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Multiply Labs
Multiply Labs offers a comprehensive portfolio of products and services, including Robotic Systems for Cell Therapy and Digital QC.
Robots for industrial-scale gene modified cell therapies production.
Real-time digital process control for pharma manufacturing parameters.
People of Multiply Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Multiply Labs
Multiply Labs has successfully raised a total of $41.32M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $11.1 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Multiply Labs
Multiply Labs has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Graph Ventures, Fenox Venture Capital and P101.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital funding is provided to startup founders.
|
Locked | Locked | Locked | |
|
Global tech sector investments are managed by Fenox Venture Capital.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in innovative early-stage companies.
|
Locked | Locked | Locked |
Investor details for Multiply Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Multiply Labs
Investment portfolio details for Multiply Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Multiply Labs
Detailed financials for Multiply Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Multiply Labs Comparisons
Peer comparison for Multiply Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Multiply Labs
Multiply Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins, Cytera and Guangdong Bogong Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Multiply Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Multiply Labs
Complete news archive for Multiply Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Multiply Labs
Multiply Labs was founded in 2016.
Multiply Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Fred Parietti is the current CEO of Multiply Labs. They have also founded this company.
Multiply Labs is a funded company, having raised a total of $41.32M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Multiply Labs is 34.
Multiply Labs was founded in 2016 in San Francisco, United States, within the biotechnology sector. Robotic systems are provided by the company to enable industrial-scale production of gene-modified cell therapies. Additionally, digital quality control and automation software is offered to support process planning and maintain digital records for manufacturing operations.
Multiply Labs's top competitors include Celltrio, ThermoGenesis and Shenzhen Shenyan Biotechnology.
Multiply Labs offers Robotic Systems for Cell Therapy and Digital QC.
Multiply Labs has 13 investors. Key investors include Graph Ventures, Fenox Venture Capital, P101, SV Tech Ventures, and Y Combinator.